Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000662084 | SCV000784421 | uncertain significance | Trichothiodystrophy 4, nonphotosensitive | 2018-03-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001855399 | SCV002247099 | uncertain significance | not provided | 2022-08-09 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with MPLKIP-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 548559). This variant is present in population databases (rs778910338, gnomAD 0.002%). This sequence change replaces serine, which is neutral and polar, with isoleucine, which is neutral and non-polar, at codon 165 of the MPLKIP protein (p.Ser165Ile). |
Ambry Genetics | RCV004026066 | SCV004994789 | uncertain significance | Inborn genetic diseases | 2023-10-02 | criteria provided, single submitter | clinical testing | The c.494G>T (p.S165I) alteration is located in exon 2 (coding exon 2) of the MPLKIP gene. This alteration results from a G to T substitution at nucleotide position 494, causing the serine (S) at amino acid position 165 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |